Live Breaking News & Updates on Degron therapeutics

Fierce Pharma Asia—AstraZeneca eyes China's innovation, plots Singapore ADC plant; FDA rejects Hengrui's PD-1 drug

Fierce Pharma Asia—AstraZeneca eyes China's innovation, plots Singapore ADC plant; FDA rejects Hengrui's PD-1 drug
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Germany , Japan , Florida , United-states , China , Singapore , Japanese , German , Chinese , British , Pascal-soriot

Takeda and Degron enter molecular glue degrader partnership worth over $1.2bn

Takeda and Degron enter molecular glue degrader partnership worth over $1.2bn
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

China , Lily-zou , Chris-arendt , Degron-gluexplorer , Degron-therapeutics , Kumquat-biosciences , Protagonist-therapeutics ,

Degron Therapeutics Announces Multi-Target Collaboration and Exclusive License Agreement with Takeda to Discover Molecular Glue Degraders

Collaboration will leverage Degron's GlueXplorer® platform to discover novel molecular glue degraders for multiple targets in oncology, neuroscience, and inflammation Degron will receive upfront payment and

Shanghai , China , Chris-arendt , Degron-gluexplorer , Yong-cang , Lily-zou , Shanghaitech-university , Head-of-research , Degron-therapeutics , Chief-scientific-officer ,

Takeda gets crafty with molecular glue deal worth $1.2B biobucks

Takeda has taken a trip all the way to Shanghai to find just the right kind of glue to stick together a $1.2 billion biobucks deal for new candidates.

Shanghai , China , Takeda-chris-arendt , Orionis-biosciences , Degron-gluexplorer , Yong-cang , Genentech , Shanghaitech-university , Novo-nordisk , Degron-therapeutics , Chris-arendt ,

Degron Therapeutics announced as winner of AFCR's 2023 BRACE Award Venture Competition

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.

China , Shanghai , Paulc-cabot , Kornelia-polyak , Yijing-jane-chen , Aleksandra-filipovic , Wilson-sonsini-goodrich-rosati , Scott-lippman , Dimitra-georganopoulou , Suzanne-topalian , Raju-kucherlapati , Jimmy-lu